Determining the appropriate retatrutide dosage is vital for achieving best outcomes . Currently, clinical trials suggest a range of dosing, typically starting at 2.4 mg once per day and gradually increasing to 12 mg once per day based on individual response and comfort. Increased doses, like the sixteen milligrams option, are also under evaluation